The global Mouth Ulcer Treatment Market is on a growth track, valued at USD 1208.96 Million in 2024 and projected to reach USD 1720.72 Million by 2033, expanding at a CAGR of 4% (2025–2033). Rising awareness about oral health, innovative drug development, and the availability of advanced treatment solutions are shaping this market’s future.

📥 Download Sample Report

Mouth ulcers are painful sores that form on the inner lining of the mouth, lips, cheeks, tongue, and gums. They are often triggered by hormonal changes, consumption of spicy foods, or use of toothpaste and rinses containing sodium lauryl sulfate. With an estimated global prevalence of 4%, and aphthous ulcers affecting nearly 25% of the population, demand for effective treatment is increasing. Despite challenges in topical applications due to saliva and moisture, the market is witnessing rapid innovation in gels, sprays, and mouthwashes designed for faster healing and fewer side effects.

Market Driving Factors

Pharmaceutical companies are expanding their portfolios with pastes, gels, creams, and antibiotic mouthwashes for recurring ulcerations. Products like Oralixir Mouth Wash, Orajel Mouth Sore Gel, and Cloratin Mouth Paint are gaining traction. Alongside modern drugs, research into herbal and natural therapies is opening new avenues. Initiatives like the Oral Cancer Foundation and the National Oral Health Program are raising awareness, while online platforms such as Netmeds, 1mg, Amazon, and Flipkart are boosting accessibility with discounts, doorstep delivery, and hassle-free returns.

Regional Insights

  • Asia Pacific is projected to record the fastest growth, supported by high tobacco consumption, cost-effective treatments, and expanding healthcare infrastructure. In India alone, nearly 240 million people consume tobacco, and ayurvedic and natural remedies are widely preferred.

  • North America holds a strong market presence, with about 4% of the U.S. population suffering from aphthous ulcers. Lifestyle factors like junk food, alcohol, and smoking contribute to demand, while companies such as 3M, Colgate-Palmolive, and Church & Dwight lead with innovative oral care solutions.

  • Europe shows promising growth, with around 20% of the U.K. population affected by recurrent ulcers. Strong research activity, like the biodegradable patch developed in London (2018) and approvals of new sprays and gargles, supports market expansion.

  • Middle East & Africa lags due to weaker healthcare infrastructure and limited awareness. However, NGOs and government programs are slowly driving attention toward cost-effective solutions.

Market Segmentation Highlights

  • By Drug Class: Analgesics & corticosteroids expected to witness fastest growth due to anti-inflammatory and pain-relieving properties.

  • By Formulation:Gels dominate thanks to their fast-acting, affordable, and non-interacting nature, making them popular among both adults and children.

  • By Indication:Aphthous stomatitis is the most common, affecting 5%–25% of the population, with multiple treatments available ranging from corticosteroids to tetracyclines.

Key Players

  • GlaxoSmithKline plc.

  • Church & Dwight Co. Inc.

  • BLISTEX INC.

  • Colgate-Palmolive Company

  • Forward Science

  • Celgene Corporation

  • Dental Herb Company

Recent Developments

  • 2019: Forward Science gained FDA clearance for OrapeuticTM, a non-opioid oral pain relief gel.

  • 2019: Celgene’s drug Otezla received FDA approval for treating oral ulcers in Behçet’s disease.

  • 2018: Researchers in the U.K. and Dermtreat developed the Rivelin patch for targeted ulcer treatment.

  • 2017: Church & Dwight acquired Water Pik, Inc. to expand oral hygiene solutions.

About Us

Straits Research is a leading global market intelligence and consulting firm, dedicated to delivering actionable insights and in-depth analysis across a wide range of industries. Our mission is to empower organizations, investors, and decision-makers with reliable data, strategic guidance, and forward-looking perspectives to help them thrive in a rapidly evolving business landscape.

Contact Us:

Email: sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
Website: https://straitsresearch.com/